1 / 24

Risk Assessment in Animal Biosafety

Risk Assessment in Animal Biosafety. Risk Assessment Factors Pathogen/agent Animal Model (species) Procedures Proposed manipulations Assigned safe work practices. Risk Assessment in Animal Biosafety. Risk Assessment Factors Personnel Protective Equipment

gerardj
Download Presentation

Risk Assessment in Animal Biosafety

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Risk Assessment in Animal Biosafety • Risk Assessment Factors • Pathogen/agent • Animal Model (species) • Procedures • Proposed manipulations • Assigned safe work practices

  2. Risk Assessment in Animal Biosafety • Risk Assessment Factors • Personnel • Protective Equipment • Personal Protective Equipment/Clothing • Engineering Controls/Safety Devices • Place/Facility for proposed research

  3. Risk Assessment in Animal Biosafety • Species • Natural infections • Unpredictable - physical hazards • Bites/scratches/splashes • Permissive species • Immune system of animal • Shedding (urine, feces, sputum) • Data? Transmission between cage mates? Between cages within room?

  4. Risk Assessment Process • Prior to initiation of work • Principal Investigator submits written risk assessment • Written proposal • Registration Form • Submitted to the IBC/IACUC/Biosafety Office

  5. Committee Risk Assessment • Questions/clarification • Has PI started w/ Risk Group? Worked towards Biosafety Level? • Verify that PI has identified: • Risks involved • Routes of exposure (nature/ lab settings) • Signs/symptoms of infection • Potential for shedding from animals • At risk personnel (those contraindicated from work) • Any special medical surveillance requirements • Serum banking, immunizations, screening/evaluation

  6. Committee Risk Assessment • Questions/clarification • Verify that PI has Selected the Appropriate: • BSL • Work Practices • PPE • Containment Equipment • To maximize protection of staff • Does Facility meet requirements for BSL selected?

  7. Risk Assessment – Proposed Procedures • Manipulations planned with the animal • Blood collection • Tissue harvesting/necropsy • Aerosols, splash risk • Sharps • Genetic manipulation

  8. Working Safely with Sharps

  9. Risk Assessment - Personnel • Immune status of host • Altered competency – suppression (disease, therapy) • Experience/Training WITH: • Agent • Animals • Procedures • Equipment • Facility • Safety Record/Attitude

  10. Risk Assessment • Ensure that the PI’s group is involved in development of the SOP! • Take ownership

  11. Risk Assessment – Equipment • Cages/housing • Open • Static, MI (Filtration Efficiency) • Ventilated Cage Racks w/ HEPA filters • PPE • Coat, gown, jump suits, full clothes change/shower • Masks, face protection, Respirators

  12. Handling Microisolator Cages

  13. Risk Assessment – Facility • Conformity w/ • ABSL-1, ABSL-2, and ABSL-3 Facilities • Compliance with pertinent: • Guidelines • Regulations • Standards • Enhanced Facilities

  14. Risk Assessment - Process • Professional Judgment Required • Expertise • IACUC • Animal model, animal care and use, animal regulations • IBC/BSO • Agent, exposure routes, med. Surveillance, facility design, equipment use/certification • Principal Investigator • Disease under study, scientific aim, lab techniques

  15. Risk Assessment - Process • After review of Risk Assessment Factors: • Select most appropriate BSL • PPE • Work Practices • Engineering Controls • Facility Controls • SOP’s prepared and approved • Clearance for each researcher/animal handler • Written Emergency Response Plans

  16. Risk Assessment Process • When you don’t have all the answers? • Be Cautious/Conservative • RA is evolving/dynamic process • Change as info comes in • Communicate RA and RM decisions to all involved

  17. LCMV – Risk Assessment Example • National Risk Group Classification • RG3 – neurotropic strains, RG2 – non-neurotropic strains • Previous LAI via airborne route • Shedding from animal (urine) • Clone 13 (persistent shedding) • Environmental stability (survives for weeks in animal waste)

  18. LCMV – Risk Assessment Example • Use of sharps • Inoculations, bleeds, necropsies • Transport of tissues, infected cells, virus • Protective Clothing • Gowns, 2 pair of gloves, booties, face protection, Respiratory Protection • Protective Equipment • Microisolator cages, biosafety cabinets • Place – ABSL-3 facility

  19. Location A Registration(s) IACUC IBC Location B Registration(s) IACUC IBC ARC Haz. Agent Form EHS RTUIA-Animals State Human Pathogen registration Case Study ExampleABSL-2 rDNA Protocol – Vaccinia Virus

  20. Location A Review of Training IACUC Orientation Animal Handling Location B Review of Training IACUC Orientation Animal Handling EHS Classes Biosafety, BBP, Chem Researcher Experience Form Case Study ExampleABSL-2 rDNA – Vaccinia Virus

  21. Location A Specific SOP created none Location B Specific SOP created Entry, exit, supplies Protective clothing Biosafety cabinet use Safe sharps (devices/use) Decontamination Emergency response Case Study ExampleABSL-2 rDNA – Vaccinia Virus

  22. Location A Additional Requirements Medical Surveillance Health history form Location B Additional Requirements Medical Surveillance Health history form Vaccinia immunization consult Employee Health review Case Study ExampleABSL-2 rDNA – Vaccinia Virus

  23. Location A Training/Inspection Facility orientation Location B Training/Inspection Facility orientation State DPH Inspection ARC/EHS/VC start-up meeting w/ researcher Researcher work practice observation Case Study ExampleABSL-2 rDNA – Vaccinia Virus

  24. Location A Implementation Vaccinia needlestick No incident report Vaccinia LAI and bacterial sepsis Hospitalization Report to State DPH Report to NIH OBA (significant incident/illness) Location B Implementation No incidents to date Case Study ExampleABSL-2 rDNA – Vaccinia Virus

More Related